Impact of anesthetic strategy on cardiac rhythm and oxidative stress in patients with STEMI undergoing urgent percutaneous coronary intervention

July 13, 2026
27
УДК:  616.132.2-089.884-073.75-092.18-06-084-89.5-032..611.14
Specialities :
Resume

In patients with ST-segment elevation acute coronary syndrome (STEMI) undergoing urgent percutaneous coronary intervention (PCI), not only timely reperfusion but also intraope­rative cardiac rhythm stability and the severity of oxidative stress are of major clinical importance. Ischemia-reperfusion myocardial injury is associated with an increased risk of arrhythmias, activation of lipid peroxidation, and depletion of antioxidant defense, which justifies the evaluation of different anesthetic management strategies during urgent PCI. Objective: to assess the effect of different anesthetic management regimens on intraoperative cardiac rhythm and oxidative stress markers in patients with STEMI undergoing urgent percutaneous coronary intervention. Materials and methods. The study included 90 patients with STEMI who were divided into 3 groups of 30 patients each according to the anesthetic regimen used. Group I received standard analgosedation with sibazone and fentanyl. Group II received multimodal anesthesia with fentanyl, propofol, paracetamol, and lidocaine. Group III received the same multimodal regimen supplemented with edaravone. Cardiac rhythm was assessed in the preoperative, intraoperative, and early postoperative periods. Oxidative stress was evaluated by measuring malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) at the beginning and at the end of the procedure. Results. In the preoperative period, rhythm disturbances were predominantly transient. During coronary artery stenting, ventricular extrasystole and sinus tachycardia were the most frequent rhythm disturbances, with the highest incidence observed in Group I. The incidence of ventricular extrasystole during the intervention was 40.0% in Group I, 23.3% in Group II, and 20.0% in Group III; the incidence of sinus tachycardia was 33.3%, 13.3%, and 10.0%, respectively. In the early postoperative period, patients in Groups II and III also demonstrated a more favorable rhythm profile. At baseline, the groups were comparable in terms of MDA, SOD, and GPx levels. By the end of the procedure, all groups showed an increase in MDA, a decrease in SOD, and an increase in GPx. The most pronounced changes were observed in Group I, whereas the least marked changes were found in Group III. Statistically significant intergroup differences at the end of the intervention were detected for SOD only (p=0.031), with the lowest level in Group I and the best preservation of enzyme activity in Group III. Conclusions. Multimodal anesthetic management in patients with STEMI undergoing urgent PCI was associated with a lower incidence of intraoperative cardiac rhythm disturbances and less pronounced oxidative stress compared with standard analgosedation. The most favorable changes were observed with multimodal anesthesia combined with edaravone, which may indicate a beneficial effect on myocardial electrical stability and and reduce oxidative stress.

References

  • 1. Rao S.V., O’Donoghue M.L., Ruel M. et al. (2025) 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 151(13): e771–e862. doi: 10.1161/CIR.0000000000001309.
  • 2. Byrne R.A., Rossello X., Coughlan J.J. et al. (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J., 44(38): 3720–3826. doi: 10.1093/eurheartj/ehad191.
  • 3. Ibanez B., James S., Agewall S. et al. (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J., 39(2): 119–177. doi: 10.1093/eurheartj/ehx393.
  • 4. Neumann F.J., Sousa-Uva M., Ahlsson A. et al. (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J., 40(2): 87–165. doi: 10.1093/eurheartj/ehy394.
  • 5. Rymer J.A., Wegermann Z.K., Wang T.Y. et al. (2024) Ventricular Arrhythmias After Primary Percutaneous Coronary Intervention for STEMI. JAMA Netw Open, 7(5): e2410288. doi: 10.1001/jamanetworkopen.2024.10288.
  • 6. Wu X., Wu M., Huang H. et al. (2025) Incidence, predictors, and prognostic impact of reperfusion-related ventricular arrhythmias in STEMI patients undergoing primary percutaneous coronary intervention. BMC Cardiovasc. Disord., 25: 494. doi: 10.1186/s12872-025-04953-9.
  • 7. Welt F.G.P., Batchelor W., Spears J.R. et al. (2024) Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement. J. Am. Coll. Cardiol., 83(22): 2196–2213. doi: 10.1016/j.jacc.2024.02.056.
  • 8. Dhalla N.S., Ostadal P., Tappia P.S. (2025) Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury. Antioxidants (Basel), 14(3): 340. doi: 10.3390/antiox14030340.
  • 9. Shen M.J., Zipes D.P. (2014) Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ. Res., 114(6): 1004–1021. doi: 10.1161/CIRCRESAHA.113.302549.
  • 10. Benabou L., Vaseghi M. (2025) Cardiac Sympathetic Innervation and Ventricular Arrhythmias in Structural Heart Disease: Current Peripheral Neuromodulation Therapies and Emerging Therapeutic Targets. Arrhythm. Electrophysiol. Rev., 14: e34. doi: 10.15420/aer.2025.24.
  • 11. Tsujita K., Shimomura H., Kawano H. et al. (2004) Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am. J. Cardiol., 94(4): 481–484. doi: 10.1016/j.amjcard.2004.05.007.
  • 12. Kikuchi K., Tancharoen S., Takeshige N. et al. (2013) The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease. Int. J. Mol. Sci., 14(7): 13909–13930. doi: 10.3390/ijms140713909.
  • 13. Dhalla N.S., Elmoselhi A.B., Hata T., Makino N. (2000) Status of myocardial antioxidants in ischemia-reperfusion injury. Can. J. Cardiol., 16(2): 241–255.
  • 14. Mužáková V., Kandár R., Vojtíšek P. et al. (2000) Selective antioxidant enzymes during ischemia/reperfusion in myocardial infarction. Physiol. Res., 49(3): 315–322.
  • 15. Buffon A., Santini S.A., Ramazzotti V. et al. (2000) Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia. J. Am. Coll. Cardiol., 35(3): 633–639. doi: 10.1016/S0735-1097(99)00581-1.
  • 16. Zhang X., Wei K.Y., Huang D. (2024) Effect of Propofol in the Cardiovascular System and its Related Mechanism Research Progress. Niger. J. Clin. Pract., 27(8): 938–944. doi: 10.4103/njcp.njcp_292_24.